Cryptocurrency & Digital Assets

Five Alberta First Nations launch a legal challenge against a federal-provincial deal, citing a lack of consent for the world's largest proposed CCS project.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

Specialist asset manager Sprott Inc. leverages a volatile market and geopolitical tensions, riding a precious metals boom to record profits and AUM growth.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

With BRINSUPRI revenues set to hit $1B, Insmed is pouring cash into a high-stakes pipeline. Can it outrun its massive burn rate to deliver the next breakthrough?

Israeli cannabis firm InterCure posts 11% revenue growth in 2025, showing resilience after conflict and making its first major push into the booming German market.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.

Hydro-Québec plans to double electricity rates for large data centers, a strategic move to manage soaring demand and revalue its clean energy resources.

A new blood test can predict when Alzheimer's symptoms will start, years in advance. This breakthrough could revolutionize research, but raises deep ethical questions.

The firm's new SBIC fund leverages a key government partnership to inject vital capital into the U.S. lower middle-market, a critical engine for the economy.

A new partnership turns agricultural waste into high-value carbon credits, boosting soil health and creating jobs in West Africa's cashew heartland.

ICANN's 2026 domain expansion offers Turkish firms a rare chance to claim new digital real estate. But is the opportunity worth the significant cost?

Early data reveals a novel immunotherapy, STC-1010, may activate the immune system against a common, treatment-resistant form of colorectal cancer.

BPCL's major bio-gas agreements in Uttar Pradesh advance national green energy goals and boost the rural economy, but face a complex road ahead.

vivo's new V70 challenges the premium market with a powerful ZEISS telephoto lens, a massive battery, robust IP69 rating, and a long-term software promise.

A landmark deal will deploy advanced Belgian particle accelerators across India, aiming to revolutionize cancer diagnostics and patient access in a booming market.

Amundi secures regulatory approval for an ICG board seat, paving the way for a 9.9% stake and signaling a major strategic push into alternative assets.

A new report reveals a shocking spike in evasive malware, with 96% hidden in encrypted traffic, forcing a radical security rethink for businesses.

A class action lawsuit reveals a massive pump-and-dump scheme targeting China Liberal Education, raising questions of corporate complicity and investor recourse.

With its CEO and CFO set for key conferences, Aptar will address investors following a strong sales quarter but facing questions on profitability.